We read with great interest the Letter to the Editor by Miduturu Sukumar and Kabilan Annadurai [1], submitted to our article recently published in the European Journal of Internal Medicine (EJIM) [2]. The primary focus of our study was to compare the production costs of daily home haemodialysis with those of conventional in-centre haemodialysis in France, using an extensive propensity score-matched population to evaluate the impact of dialysis schedules, followed by an analysis of the survival among incident patients [2].
